Cure Pharmaceutical Holding Corp. (CURR) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 67 transactions totaling $879.6K, demonstrating a bearish sentiment with -$817.8K in net insider flow. The most recent transaction on Aug 12, 2022 involved a transaction of 226,764 shares valued at $0.
No significant insider buying has been recorded for CURR in the recent period.
No significant insider selling has been recorded for CURR in the recent period.
Based on recent SEC filings, insider sentiment for CURR is bearish with an Insider Alignment Score of 4/100 and a net flow of -$817.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Cure Pharmaceutical Holding Corp. (CURR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading CURR stock, having executed 67 transactions in the past 90 days. The most active insider is Change Investigation, Innovation &. Investment Company, Llc Climate (Executive), who has made 45 transactions totaling $1.1M.
Get notified when executives and directors at CURR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | J. Costantino Robert | Executive | Award | 226,764 | $N/A | $0 | |
| Jul 25, 2022 | Steven Davidson Robert | Executive | Award | 220,795 | $N/A | $0 | |
| Jul 25, 2022 | Bagg Gerald | Executive | Award | 220,795 | $N/A | $0 | |
| Jul 22, 2022 | Steven Davidson Robert | Executive | Award | 500,000 | $N/A | $0 | |
| May 27, 2021 | Berlent Jonathan | Executive | Purchase | 10,000 | $0.69 | $6.9K | |
| May 25, 2021 | Duitch Nancy | Executive | Purchase | 1,000 | $0.70 | $700 | |
| May 24, 2021 | Steven Davidson Robert | Executive | Purchase | 6,443 | $0.69 | $4.4K | |
| May 21, 2021 | Duitch Nancy | Executive | Purchase | 5,000 | $0.74 | $3.7K | |
| May 21, 2021 | Steven Davidson Robert | Executive | Purchase | 7,400 | $0.71 | $5.3K | |
| Dec 18, 2020 | Steven Davidson Robert | Executive | Purchase | 2,172 | $1.44 | $3.1K | |
| Dec 18, 2020 | Steven Davidson Robert | Executive | Purchase | 2,300 | $1.42 | $3.3K | |
| Dec 18, 2020 | Steven Davidson Robert | Executive | Purchase | 2,415 | $1.45 | $3.5K | |
| Aug 20, 2020 | K. Bell John | Executive | Award | 17,601 | $N/A | $0 | |
| Aug 19, 2020 | Z. Salkind Gene | Executive | Award | 50,000 | $N/A | $0 | |
| Aug 19, 2020 | Z. Salkind Gene | Executive | Award | 100,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 40 | $848.7K | 73.1% |
Exercise(M) | 5 | $281.6K | 24.2% |
Purchase(P) | 8 | $30.9K | 2.7% |
Award(A) | 13 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at Cure Pharmaceutical Holding Corp. has increased, with 11 insiders executing 67 transactions across all time. Total sales of $848.7K significantly outpace purchases of $30.9K, resulting in a net outflow of $817.8K. This selling activity appears largely discretionary, which may warrant closer attention from investors.